PRICE T ROWE ASSOCIATES INC /MD/ - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$35,964
+2.3%
1,555,514
+16.0%
0.01%0.0%
Q2 2023$35,152
+399.4%
1,340,630
+390.3%
0.01%
+400.0%
Q1 2023$7,039
+13.4%
273,427
+14.6%
0.00%0.0%
Q4 2022$6,207
-99.9%
238,653
-4.1%
0.00%0.0%
Q3 2022$7,101,000
+19.5%
248,855
+3.1%
0.00%0.0%
Q2 2022$5,944,000
-66.6%
241,443
-23.5%
0.00%
-50.0%
Q1 2022$17,804,000
-7.9%
315,442
+1.1%
0.00%0.0%
Q4 2021$19,340,000
-0.8%
312,041
+1.5%
0.00%0.0%
Q3 2021$19,502,000
-23.4%
307,407
-0.5%
0.00%0.0%
Q2 2021$25,459,000
+5.6%
308,937
-5.7%
0.00%0.0%
Q1 2021$24,107,000
+1.9%
327,679
+0.5%
0.00%0.0%
Q4 2020$23,655,000326,1800.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$480,558,00031.49%
Consonance Capital Management LP 1,199,339$98,838,00011.90%
Boxer Capital, LLC 2,075,905$171,075,0006.04%
Perceptive Advisors 9,699,824$799,362,0005.19%
Orbimed Advisors 6,044,266$498,108,0005.04%
Samsara BioCapital, LLC 169,852$13,998,0001.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,375,775$113,378,0001.50%
SPHERA FUNDS MANAGEMENT LTD. 195,117$16,080,0001.09%
Artal Group S.A. 500,000$41,205,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$46,032,0000.82%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders